Search Results for Early Access Program

Showing 1 – 1

Regulatory Explainer: FDA's Expanded Access (Compassionate Use) Program By Alexander Gaffney, RAC - Published 04 February 2014

In our latest Regulatory Explainer, we break down FDA's expanded access-sometimes referred to as compassionate use-regulations to understand how they work.

Categories: News, US, CDER, Biologics and biotechnology, Clinical, Drugs, Ethics

Tags: Investigational IND, Early Access Program, Compassionate Use Program, Regulatory Explainer, Compassionate Use, IND, Expanded Access